EW250117P70000
- 0.50
- -0.30-37.50%
Edwards Lifesciences Newsroom
Weekly Buzz: So far, Santa is Letting us Down
Friday Market Pulls Back, Led by Mag Seven Decline | Live Stock
A Look At The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Edwards Lifesciences Scores a Win at CMS for TTVR
Edwards Lifesciences Corporation (NYSE:EW) Is Largely Controlled by Institutional Shareholders Who Own 85% of the Company
Jim Cramer: Is Edwards Lifesciences (EW) Poised for a Comeback?
Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Daily short sale tracking: Micron Technology's short volume increased by 4 million, with a short sale ratio of 11%
Is the Options Market Predicting a Spike in Edwards (EW) Stock?
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Deutsche Bank Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $85
Deutsche Bank Sticks to Its Buy Rating for Edwards Lifesciences (EW)
Baird Adjusts Edwards Lifesciences Price Target to $70 From $68, Maintains Neutral Rating
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
Morgan Stanley Downgrades Edwards Lifesciences(EW.US) to Sell Rating, Cuts Target Price to $46
Edwards Lifesciences: Competitive Pressures and Valuation Concerns Lead to Sell Rating
Tuesday, Tech Pulls Back, While Traders Await FOMC Rate | Wall Street Today
Bernstein Downgrades Edwards Lifesciences(EW.US) to Sell Rating, Announces Target Price $73